Literature DB >> 27076087

LDOC1 Gene Expression in Men With Klinefelter Syndrome.

Michele Salemi1, Rosita A Condorelli2, Giusi Longo3, Valentina Bullara2, Carmelo Romano4, Cristina Campagna2, Paolo Bosco4, Sandro La Vignera2, Aldo E Calogero2.   

Abstract

Klinefelter syndrome (KS) results from an extra chromosome X, which is due to the failure of normal chromosomal segregation during meiosis. Patients with KS have gynecomastia, small testes, and azoospermia. Apoptosis is a mechanism responsible for the normal regulation of spermatogenesis. LDOC1 gene is a known regulator of nuclear factor mediated pathway to apoptosis through inhibition of nuclear factor kappa B (NF-kappaB). Furthermore, the transcription factor myeloid zinc finger gene 1 (MZF-1) has been shown to interact with LDOC1 and to enhance LDOC1 activity favoring apoptosis. We investigated the expression of LDOC1 gene mRNA, by quantitative reverse transcription polymerase chain reaction (qRT-PCR), in peripheral blood leukocytes of 13 patients with KS compared to 13 healthy men chosen as controls. LDOC1 expression was higher in 9 of the 13 KS patient compared to normal controls. These finding led us to hypothesize that LDOC1 gene upregulation may play a role in the spermatogenesis derangement observed in patients with KS.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Klinefelter syndrome; LDOC1 gene; apoptosis; azoospermia; qRT-PCR

Mesh:

Substances:

Year:  2016        PMID: 27076087      PMCID: PMC6807188          DOI: 10.1002/jcla.21870

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

Review 1.  Germ cell suicide: new insights into apoptosis during spermatogenesis.

Authors:  C G Print; K L Loveland
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

2.  Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study.

Authors:  Anders Bojesen; Svend Juul; Claus Højbjerg Gravholt
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

3.  A case of human intersexuality having a possible XXY sex-determining mechanism.

Authors:  P A JACOBS; J A STRONG
Journal:  Nature       Date:  1959-01-31       Impact factor: 49.962

4.  Expression of LDOC1 mRNA in leucocytes of patients with Down's syndrome.

Authors:  Michele Salemi; Concetta Barone; Carmelo Romano; Federico Ridolfo; Roberto Salluzzo; Francesco Scillato; Cataldo Scavuzzo; Filippo Caraci; Aldo E Calogero; Corrado Romano; Paolo Bosco
Journal:  J Genet       Date:  2012       Impact factor: 1.166

5.  WAVE3 functions as a negative regulator of LDOC1.

Authors:  Kiyohito Mizutani; Daisuke Koike; Shiro Suetsugu; Tadaomi Takenawa
Journal:  J Biochem       Date:  2005-11       Impact factor: 3.387

6.  LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and Parkinson's disease.

Authors:  Michele Salemi; Domenica Giuffrida; Maria C Giuffrida; Pier Franco Soma; Alessandro Rolfo; Laura Cimino; Rosita A Condorelli; Roberto Castiglione; Sandro La Vignera; Aldo E Calogero
Journal:  Tumori       Date:  2012 May-Jun       Impact factor: 2.098

Review 7.  Klinefelter's syndrome and its variants: a hormonal and chromosomal study.

Authors:  C A Paulsen; D L Gordon; R W Carpenter; H M Gandy; W D Drucker
Journal:  Recent Prog Horm Res       Date:  1968

8.  Identification of a novel gene, LDOC1, down-regulated in cancer cell lines.

Authors:  K Nagasaki; T Manabe; H Hanzawa; N Maass; T Tsukada; K Yamaguchi
Journal:  Cancer Lett       Date:  1999-06-01       Impact factor: 8.679

9.  High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter's syndrome.

Authors:  C Foresta; C Galeazzi; A Bettella; M Stella; C Scandellari
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

10.  Study of autoimmunity in Klinefelter's syndrome and idiopathic hypogonadotropic hypogonadism.

Authors:  Cagatay Oktenli; Zeki Yesilova; Ismail Hakki Kocar; Ugur Musabak; Metin Ozata; Ali Inal; Davut Gül; Yavuz Sanisoglu
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.